You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Eyegate Pharmaceuticals CFO resigns
S&P Capital IQ Pro | Unrivaled Sector Coverage
S&P Capital IQ Pro | Powering Your Edge
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Investment Research Analysts Providing Greater Coverage on Inflation
Ryan Brenneman is no longer Eyegate Pharmaceuticals Inc.'s CFO and principal financial and accounting officer.
Brenneman resigned from the positions, prompting company President and CEO Stephen From to assume the role of principal financial and accounting officer.